Login or sign up
For business
Average ratingGreat
4.1/ 5

Based on 10 reviews

540%
430%
330%
20%
10%
Ask AI

Ask Trustburn about Newsummitbio

Based on 10 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Samori Joseph
Reviews 1

The service provided by Newsummitbio is excellent. I am extremely satisfied with their products and the level of customer support offered. The team is highly professional and knowledgeable. They have always been prompt in addressing any concerns or queries I had. I highly recommend Newsummitbio for their top-notch service!

Wanda Price
Reviews 1

I recently purchased some products from the website newsummitbio.com. The quality of the products is great, and the prices are reasonable too. The delivery was also fast and well-packaged. Overall, I'm really happy with my purchase and would definitely consider buying from them again.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Newsummitbio

Shanghai Newsummit Biopharma is a Chinese provider of comprehensive pharmaceuticals industrialization, modularization, standardization, and large-scale R&D services.

Newsummit is focused on the optimization and integration of industrial resources through the alliance of governance, production, education, research and capital, to serve scientists, entrepreneurs, investors, and the government. These services include assisting the scientists to facilitate the achievements of new medicine and realize the industrialization; providing entrepreneurs with achievements with industrial value and industry incubation; helping investors to shorten investment cycle and reduce investment risk; serving the government by integrating resources from China's New Medicines Public Service Platform; and strengthening the international competitiveness of China's New Medicines' self-research and development.